the aid library

LIST OPTIONS

Filter

3421

Sort by:

Direction:

Download (148)

View PDF (137)

Projet pilote de l’accès à base communautaire des contraceptifs injectables au Bénin

USAID; Ministère de la Santé Benin, Advancing Partners and Communities USAID; Ministère de la Santé Benin, Advancing Partners and Communities (2011) C2

Les preuves de recherche mondiale sur l’accès à base communautaire des contraceptifs injectables (CBA2I) montrent que les agents de santé communautaire formés (ASC) peuvent en toute sécurité, fournir des services de contraception injectable acceptables et efficaces dans leurs communauté... more

Download (552)

View PDF (1991)

Core Competencies in Adolescent Health and Development for Primary Care Providers

Pierre André Michaud, Valentina Baltag, Venkatraman Chandra-Mouli et al. World Health Organization (WHO) (2015)

Including a Tool to Assess the Adolescent Health and Development Component in Pre-Service Education of Health-Care Providers

Download (226)

View PDF (1217)

Coverage, Timelines, and Determinants of Incomplete Immunization in Bangladesh

Sheikh, Nurnabi; Sultana, Marufa et al. (2018) CC

Trop. Med. Infect. Dis. 2018, 3, 72;
The study identified some key determinants of untimely and incomplete childhood vaccinations in the context of Bangladesh. The findings will contribute to the improvement of age-specific vaccination and support policy makers in taking the necessary control ... more

Download (120)

View PDF (175)

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO

Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?

Download (171)

View PDF (402)

Myanmar National Health Plan 2017-2021

The Republic of the Union of Myanmar, Ministry of Health and Sports (2016) C1

The National Health Plan (NHP) aims to strengthen the country’s health system and pave the way towards Universal Health Coverage (UHC),choosing a path that is explicitly pro-poor. The main goal of NHP 2017-2021 is to extend access to a Basic Essential Package of Health Services (EPHS) to the entir... more

Download (480)

View PDF (880)

State of Health in the WHO African Region
recommended

World Health Organization WHO, Regional Office African Region (2018) C_WHO

This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs. There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50... more

Download (183)

View PDF (246)

Rwanda: HEALTH SECTOR ANNUAL REPORT July 2014-June 2015

Ministry of Health, Rwanda (2015) C2

For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable ... more

Download (90)

View PDF (127)

Plan national de devloppement sanitaire 2009-2018

Ministère de la santé et de la prévention - Republique Sénégal (2009) C2

Le présent Plan National de Développement Sanitaire (PNDS) couvre la période 2009-2018. Il s’inscrit dans la perspective de l’accélération de la mise en œuvre des différents programmes de prévention et d’offres de services de santé. Son objectif est de contribuer à l’atteinte des o... more

Download (128)

View PDF (133)

Guide pratique pour la gestion des fausses informations sur les vaccins

PGP, UNICEF, Yale Institute for Global Health (2021) CC

Cette ressource a été élaborée pour faciliter le développement de plans d’action nationaux stratégiques et bien coordonnés afin de contrer rapidement la désinformation sur les vaccins et d’encourager la demande de vaccination éclairée par l’écoute sociale.

Download (158)

View PDF (129)

Orientação para a elaboração de um plano nacional de operacionalização da vacinação contra a COVID-19 : 1º de junho 2021

Unicef, OPAS OPAS (2021) C_WHO

Guideline for the development of a national plan for the operationalization of vaccination against COVID-19

Download (111)

View PDF (122)

Ideal Clinic Frameworks and Manual Version 19 (July 2020) - Framework

National Department of Health South Africa (2020) CC

The Ideal Clinic Realisation and Maintenance (ICRM) programme was initiated by the National Department of Health in July 2013 in order to systematically improve primary health care (PHC) facilities and the quality of care they provide. The Ideal Clinic framework/dashboard sets out the standards for ... more

Download (133)

View PDF (149)

Ideal Clinic Frameworks and Manual Version 19 (July 2020) | Manual

National Department of Health South Africa (2020) CC

The Ideal Clinic manual has been developed to assist managers at various levels of healthcare service provision to correctly interpret and understand the requirement for achieving the elements as depicted in the Ideal Clinic framework/dashboard. It can therefore be regarded as a reference document w... more

Download (128)

View PDF (185)

Meeting of the Strategic Advisory Group of Experts on Immunization, October 2022: conclusions and recommendations

World Health Organisation (WHO) (2023) C_WHO

The Strategic Advisory Group of Experts (SAGE) on Immunization held a meeting on 3-6 October 2022. This report summarizes the discussions, conclusions and recommendations. It covers the following items: Global Reports Immunization Agenda 2030 and Regional reports Monkeypox RSV COVID-19 vacci... more

Download (90)

View PDF (366)

Human Rights based research into COVID-19 related violations with focus on persons with disabilities

Malawi Human Rights Commission (2021) CC

The goal of the study was to assess the feasibility of the COVID-19 measures and their resultant impact on Persons with Disabilities in Malawi. Specifically, the study addressed the following objectives: a) To evaluate Government’s response to COVID-19 following the adoption of the new measures... more

Download (77)

View PDF (108)

Guatemala's Health Emergency Appeal 2023

World Health Organisation (WHO) (2023) C_WHO

Recovery from COVID-19 has been challenging in Guatemala. As a result of the prolonged socio-economic impact of the pandemic, the average poverty rate nationwide has increased by almost 5%. This rise in the poverty level further exacerbates preexisting vulnerabilities and erodes the limited safety n... more

Download (96)

View PDF (126)

Colombia's Health Emergency Appeal 2023

World Health Organisation (WHO) (2023) C_WHO

Colombia is characterized by a fragile and prolonged humanitarian context marked by recurrent multi-hazards affecting its territories and combined with severe structural and systemic challenges within the health system. Recent shocks, including the COVID-19 pandemic, growing violence within the Col... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (83)

View PDF (99)

Matière de Santé Reproductive: Priorités stratégiques 2022-2026

Centers for Disease Control and Prevention (CDC) (2023) CC

En 2006, la session extraordinaire des ministres de la Santé de l’Union africaine a adopté le Plan d’action de Maputo pour la mise en œuvre du cadre politique continental sur la santé et les droits sexuels et reproductifs (SDSR), qui a expiré fin 2015. L’objectif était que toutes les pa... more

Download (183)

View PDF (143)

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more

Download (106)

View PDF (116)

Building better immunity: A life course approach to healthy longevity

Pan American Health Organization PAHO (2023) C_WHO

As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt... more

State of Health in the WHO African Region recommended

State of Health in the WHO African Region
recommended